Top compounds associated with response to TMIE


Feature Type Standardized
Nominal ANOVA
mRNA dexamethasone CTRPv2 pan-cancer AAC 0.12 0.0002
mRNA Vandetanib CCLE pan-cancer AAC 0.18 0.0002
mRNA hyperforin CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA dacarbazine CTRPv2 pan-cancer AAC 0.11 0.0002
mRNA Nutlin-3 CTRPv2 pan-cancer AAC 0.12 0.0003
mRNA ABT-199 CTRPv2 pan-cancer AAC 0.15 0.0004
mRNA alisertib CTRPv2 pan-cancer AAC 0.11 0.0005
mRNA AZD-2281 CTRPv2 pan-cancer AAC 0.12 0.0005
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 0.0007
Download CSV